Adjusted prevalence ratios (PR) using different cut-points for low AMH values
| AMH <1.0 ng/mL | AMH below 25th percentile* | |||
| Model 1† | Model 2‡ | Model 1† | Model 2‡ | |
| PR (95% CI) | PR (95% CI) | PR (95% CI) | PR (95% CI) | |
| SLE/CYC− vs comparison | 1.68 (0.97 to 2.91) | 1.62 (0.93 to 2.82) | 1.55 (0.97 to 2.47) | 1.55 (0.97 to 2.47) |
| SLE/CYC+ vs comparison | 2.90 (1.45 to 5.78) | 2.90 (1.29 to 6.51) | 2.66 (1.59 to 4.45) | 2.43 (1.40 to 4.22) |
| SLE/CYC+ vs SLE/CYC− | 1.72 (0.91 to 3.24) | 1.79 (0.81 to 3.95) | 1.72 (1.09 to 2.70) | 1.57 (0.94 to 2.61) |
*25th percentile cut-point categories were assigned separately for those aged 22–34 and 35–40 years.
†Adjusting for age at interview (continuous).
‡Adjusting for age at interview (continuous), body mass index (underweight: <18.5 kg/m2, normal weight: 18.5–<25 kg/m2, overweight: 25–<30 kg/m2 and obese: ≥30 kg/m2) and hormonal contraception in the previous 12 months.
AMH, anti-Müllerian hormone; CYC, cyclophosphamide.